Elite ingenius
The ELITe InGenius is a compact and versatile laboratory instrument designed for nucleic acid amplification and detection. It performs real-time PCR analysis to identify and quantify specific DNA or RNA sequences. The system is capable of processing multiple samples simultaneously and provides automated data analysis.
Lab products found in correlation
14 protocols using elite ingenius
Nasopharyngeal RNA Extraction Protocol
Sputum Nucleic Acid Extraction
SARS-CoV-2 Diagnostic Testing in Clinical Samples
RNA Extraction and rRT-PCR Analysis for SARS-CoV-2
Prior to RNA extraction, collection tubes were vortexed; 200 or 400 µL of VTM were transferred to 2 mL tubes for RNA extraction using Magna Pure Compact (Roche, Germany) or ELITe InGenius (ELITechGroup, France) systems with elution set to 100 µL. Finally, 5 µL of extracted RNA was used as template for the rRT-PCR.
Rapid Dipstick Assay for Leukocyte Esterase in Urine
M. genitalium was identified as part of the routine diagnostics for STI infections using the automated platform ELITe InGenius® (ELITechGroup S.p.a., Torino, Italy). The FTD Urethritis plus kit (Fast Track Diagnostics, Luxembourg) was employed during 2018 and 2019, while the STI PLUS ELITe MGB®Kit (ELITechGroup S.p.a., Torino, Italy) was utilized from 2019 until the end of 2023, following the manufacturers’ instructions.
SARS-CoV-2 Detection: Automated Extraction and PCR
Multicenter COVID-19 Hospitalization Cohort
The RT-PCR results for the SARS-CoV-2 were obtained through one of the following tests: LightCycler® Multiplex RNA Virus Master (Roche Life Science, Penzberg, Germany) at a LightCycler® 480 Instrument II (Roche Life Science, Penzberg, Germany), Cobas® SARS-CoV-2 Test (Roche® Diagnostics) at a Cobas® 6800 (Roche® Diagnostics), AllplexTM SARS-CoV-2 Master Assay (Seegene Inc.) at a CFX96® Real-Time (Bio-Rad®), GeneFinderTM COVID-19 PLUS RealAmp Kit (OSANG Healthcare Co, Ltd.) at ELITe InGenius® (ELITechGroup®) or QuantGene 9600 (Hangzhou Bioer Technology Co. Ltd.), Xpert®Xpress SARS-CoV-2 (Cepheid®) at a GeneXpert® (Cepheid®).
All eligible patients were followed till the closure of case i.e. either discharge or mortality.
SARS-CoV-2 Screening and Antibody Detection
The electrochemiluminescence immunoassay (ECLIA) Elecsys® anti-SARS-CoV-2 was used to detect immunoglobulins (IgG/A/M) for anti-SARS-CoV-2-S (Roche Diagnostics International Ltd, Rotkreuz, Switzerland). The assay uses a recombinant protein representing the RBD of the S antigen in a double-antigen sandwich assay format from SARS-CoV-2 wild-type (WT) (Wuhan-Hu-1) strain. Serum samples of 20 μL are collected using EDTA tubes. The results are expressed as U/mL, the cut-off was 0.8 U/mL, and the upper limit of detection was 250 U/mL. Since the antibody titers elicited in immunized individuals were very high, we tested all serum samples at a dilution of 1:20, in accordance with Roche, so the upper limit of detection was raised to 5000 U/mL and the dynamic range could be extended.
Automated SARS-CoV-2 Detection Workflow
Comparative Analysis of SARS-CoV-2 Detection
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!